Budesonide Tablets, Capsules & Granules: Uses & Dosage
Complete guide to budesonide oral medications: uses, dosage, side effects, and precautions.
About Budesonide
Budesonide is a potent corticosteroid, commonly referred to as an oral steroid, used to treat various inflammatory conditions affecting the gastrointestinal tract and respiratory system. This medication is particularly effective for managing inflammatory bowel disease and related gastrointestinal conditions that cause chronic inflammation. Budesonide works by reducing inflammation in the affected tissues, thereby easing symptoms associated with disease flare-ups.
The medication is available under several brand names including Budenofalk®, Entocort® CR, Cortiment®, Jorveza®, and Kinpeygo®. These various formulations are designed with different release mechanisms to target specific areas of the gastrointestinal tract, allowing clinicians to tailor treatment based on the location and severity of inflammation.
Available Formulations
Budesonide comes in multiple forms to suit different treatment needs:
- Standard capsules
- Modified-release capsules
- Modified-release tablets
- Granules
- Orodispersible (melt-in-the-mouth) tablets
What Is Budesonide Used For?
Budesonide is prescribed for several inflammatory and autoimmune conditions affecting the digestive system. The primary uses include:
Inflammatory Bowel Disease
Crohn’s disease is a chronic inflammatory condition affecting the entire gastrointestinal tract, causing inflammation that can penetrate deeply into the bowel wall. Symptoms include abdominal pain, diarrhea, weight loss, and fever. Budesonide is used to induce remission in mild to moderate Crohn’s disease, with adult patients typically prescribed 9 mg orally once daily for eight weeks.
Ulcerative colitis specifically affects the large intestine and rectum, causing inflammation of the inner lining that leads to ulceration and bleeding. This results in symptoms such as abdominal pain and diarrhea. Budesonide serves as a second-line therapeutic agent and promotes mucosal healing of distal lesions. For distal ulcerative colitis affecting the rectum and sigmoid colon not extending beyond 40 cm from the anal verge, a rectal foam formulation is recommended at one metered dose applied rectally twice daily for 14 days, followed by once daily for 28 days.
Other Inflammatory Conditions
Collagenous colitis is a chronic inflammatory condition of the large bowel that causes severe diarrhea. Budenofalk® brand budesonide is specifically used to treat this condition and reduce associated diarrhea.
Autoimmune hepatitis, a type of chronic liver inflammation where the immune system attacks liver cells, can be treated with Budenofalk® capsules. Similarly, autoimmune nephropathy and related kidney conditions may be managed with budesonide therapy.
Eosinophilic esophagitis (EoE) is an allergic inflammatory condition of the esophagus that causes swallowing difficulties and food impaction. Oral viscous budesonide improves symptomatic parameters and reverses endoscopic and histological changes. In Europe, budesonide is approved for adult use, while in the United States it is approved for short-term use (12 weeks) in patients 11 years of age and older.
How Budesonide Works
Budesonide exerts a powerful topical anti-inflammatory effect on the respiratory and gastrointestinal systems. As a glucocorticoid, it suppresses certain immune responses and reduces inflammation by controlling the symptoms of inflammatory diseases with minimal disruption to the hypothalamic-pituitary-adrenal (HPA) axis compared to therapeutically equivalent doses of oral prednisone.
The medication can be administered via multiple routes—oral, rectal, nasal, and inhalation—each with specific purposes and advantages depending on the targeted area and condition being treated. While budesonide is absorbed into systemic circulation and becomes active at higher doses, the beneficial effects of minimizing HPA axis suppression are preserved only when doses remain within recommended ranges and patients are titrated to the minimum effective dose.
Dosage and Administration
Budenofalk® Capsules
When prescribed Budenofalk® capsules, the usual dose is one capsule three times daily, taken 30-60 minutes before a meal, or alternatively, three capsules taken together in the morning before breakfast. Swallow the capsules with a drink of water.
Entocort® Capsules
For Entocort® capsules, the standard dose is three capsules taken together in the morning, preferably before breakfast. Swallow with a drink of water.
Budenofalk® Granules
Granule formulations are taken as a single dose of one sachet in the morning, 30-60 minutes before breakfast. Place the granules on your tongue and swallow them with a drink of water. Do not chew the granules as you swallow.
Cortiment® Tablets
When given Cortiment® tablets, the usual dose is one tablet in the morning. Swallow the tablet with a drink of water; it can be taken with or without food.
Dosing may vary based on individual response, disease severity, and the specific formulation prescribed. Always follow your healthcare provider’s instructions regarding dosage and administration.
Before Taking Budesonide
Important Precautions and Contraindications
Before starting budesonide, inform your healthcare provider if you currently have any of the following conditions:
- High blood pressure
- Osteoporosis
- Diverticulitis
- An underactive thyroid gland
- Epilepsy
- Cataracts
- Myasthenia gravis (a condition causing severe muscle weakness)
Additionally, disclose to your healthcare provider if you have ever experienced:
- A blood clot in a blood vessel
- A stomach ulcer
- Mental health problems such as depression or psychosis
Drug Interactions
Budesonide may interact with other medications. Inform your healthcare provider about all medicines you take, including over-the-counter medications and supplements, as certain drugs may affect how budesonide works or increase the risk of side effects.
Side Effects and Adverse Reactions
Common Side Effects
Patients taking budesonide may experience common side effects including:
- Headache
- Nausea
- Vomiting
- Upset stomach
These side effects are often mild and may diminish with continued use as your body adjusts to the medication.
Serious Side Effects
Serious side effects include an increased risk of infections. Contact your healthcare provider immediately if you develop an infection or experience symptoms such as:
- Fever
- Chills
- Cough
- Tiredness or unusual fatigue
Because budesonide is a corticosteroid that suppresses immune function, patients may be more susceptible to infections. Long-term use may also increase risks associated with corticosteroid therapy, including bone density loss and increased blood sugar levels.
Special Considerations and Important Information
Pregnancy and Breastfeeding
Discuss with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. While budesonide is often considered safer than systemic corticosteroids due to its localized action, your doctor must evaluate the potential risks and benefits for your specific situation.
Long-Term Use Monitoring
Regular follow-up appointments are essential during budesonide therapy. Your healthcare provider may recommend periodic monitoring for side effects, particularly regarding bone health, blood pressure, and glucose levels, especially with prolonged use.
Medication Storage
Store budesonide at room temperature away from moisture and heat. Keep all medications out of reach of children and pets. Do not use budesonide after the expiration date printed on the package.
Comparison of Budesonide Formulations
| Formulation | Brand Name | Typical Dose | Frequency | Timing with Meals |
|---|---|---|---|---|
| Capsules (standard) | Budenofalk® | 1 capsule | 3 times daily | 30-60 min before meal |
| Capsules (modified-release) | Entocort® CR | 3 capsules | Once daily | Before breakfast |
| Tablets (modified-release) | Cortiment® | 1 tablet | Once daily | With or without food |
| Granules | Budenofalk® | 1 sachet | Once daily | 30-60 min before breakfast |
| Orodispersible tablets | Jorveza® | Variable | As prescribed | As directed |
Frequently Asked Questions
Q: How long does it typically take for budesonide to work?
A: Some patients may experience symptom improvement within days to weeks, though full therapeutic benefit may take several weeks of consistent use. Your healthcare provider will assess your response and adjust treatment accordingly.
Q: Can I stop taking budesonide abruptly?
A: No. Do not stop taking budesonide without consulting your healthcare provider. Stopping suddenly, especially after prolonged use, may cause adverse effects. Your doctor will provide instructions for gradually reducing the dose when appropriate.
Q: Is budesonide a cure for Crohn’s disease or ulcerative colitis?
A: No, budesonide does not cure inflammatory bowel disease, but it effectively reduces inflammation and manages symptoms during flare-ups. It helps induce and maintain remission, allowing patients to function better and reducing complications.
Q: What should I do if I miss a dose?
A: If you miss a dose, take it as soon as you remember unless it is nearly time for your next dose. Never take a double dose. Contact your healthcare provider or pharmacist for specific guidance based on your dosing schedule.
Q: Can budesonide interact with herbal supplements?
A: Some herbal supplements may interact with budesonide. Always inform your healthcare provider about any supplements you take. St. John’s Wort, for example, may affect corticosteroid metabolism.
Q: Is budesonide safe for children?
A: Budesonide is used in children for certain conditions, such as eosinophilic esophagitis (approved for ages 11 and older in the US) and Crohn’s disease (approved for ages 8 and older). Dosing and formulation differ for pediatric patients, so consult your child’s healthcare provider.
Q: What is the difference between budesonide and other corticosteroids?
A: Budesonide, particularly in delayed and extended-release formulations, has a localized action in the gastrointestinal tract with minimal systemic absorption, reducing side effects compared to systemic corticosteroids like prednisone while maintaining therapeutic efficacy.
Additional Considerations
Budesonide remains an effective treatment option for inflammatory bowel disease and related gastrointestinal conditions. Its ability to target inflammation locally while minimizing systemic effects makes it a valuable therapeutic tool. However, individual response varies, and close collaboration with your healthcare provider ensures optimal treatment outcomes. Regular monitoring, adherence to prescribed dosages, and open communication about side effects or concerns are essential for safe and effective budesonide therapy.
References
- Budesonide tablets, capsules and granules – Patient.info — Patient.info. Accessed January 13, 2026. https://patient.info/medicine/budesonide-tablets-capsules-and-granules-budenofalk-entocort-cr-cortiment
- Budesonide: Uses, Interactions, Mechanism of Action — DrugBank (University of Alberta). Accessed January 13, 2026. https://go.drugbank.com/drugs/DB01222
- Budesonide – StatPearls — NCBI Bookshelf, National Center for Biotechnology Information. Accessed January 13, 2026. https://www.ncbi.nlm.nih.gov/books/NBK563201/
- Budesonide: MedlinePlus Drug Information — U.S. National Library of Medicine. Accessed January 13, 2026. https://medlineplus.gov/druginfo/meds/a608007.html
- Budesonide (Entocort EC, Uceris) – Uses, Side Effects, and More — WebMD. Accessed January 13, 2026. https://www.webmd.com/drugs/2/drug-22007/entocort-ec-oral/details
Similar Articles
Read full bio of medha deb
